Literature DB >> 30309972

Interventions to improve retention-in-care and treatment adherence among patients with drug-resistant tuberculosis: a systematic review.

Stephanie Law1, Amrita Daftary1,2,3, Max O'Donnell3,4, Nesri Padayatchi3, Liviana Calzavara5, Dick Menzies1,2.   

Abstract

The global loss to follow-up (LTFU) rate among drug-resistant tuberculosis (DR-TB) patients remains high at 15%. We conducted a systematic review to explore interventions to reduce LTFU during DR-TB treatment.We searched for studies published between January 2000 and December 2017 that provided any form of psychosocial or material support for patients with DR-TB. We estimated point estimates and 95% confidence intervals of the proportion LTFU. We performed subgroup analyses and pooled estimates using an exact binomial likelihood approach.We included 35 DR-TB cohorts from 25 studies, with a pooled proportion LTFU of 17 (12-23)%. Cohorts that received any form of psychosocial or material support had lower LTFU rates than those that received standard care. Psychosocial support throughout treatment, via counselling sessions or home visits, was associated with lower LTFU rates compared to when support was provided through a limited number of visits or not at all.Our review suggests that psychosocial support should be provided throughout DR-TB treatment in order to reduce treatment LTFU. Future studies should explore the potential of providing self-administered therapy complemented with psychosocial support during the continuation phase.
Copyright ©ERS 2019.

Entities:  

Year:  2019        PMID: 30309972     DOI: 10.1183/13993003.01030-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  21 in total

1.  Electronic Dose Monitoring Identifies a High-Risk Subpopulation in the Treatment of Drug-resistant Tuberculosis and Human Immunodeficiency Virus.

Authors:  Jennifer R Zelnick; Amrita Daftary; Christina Hwang; Amy S Labar; Resha Boodhram; Bhavna Maharaj; Allison K Wolf; Shinjini Mondal; K Rivet Amico; Catherine Orrell; Boitumelo Seepamore; Gerald Friedland; Nesri Padayatchi; Max R O'Donnell
Journal:  Clin Infect Dis       Date:  2021-10-05       Impact factor: 9.079

2.  Public health and hospital-based nursing intersection: Case study of drug-resistant tuberculosis patients.

Authors:  Elize Pietersen; Kim Anderson; Yuri F van der Heijden
Journal:  Public Health Nurs       Date:  2022-01-06       Impact factor: 1.462

3.  Causes of loss to follow-up from drug-resistant TB treatment in Khayelitsha, South Africa.

Authors:  B Memani; B Beko; N Dumile; E Mohr-Holland; J Daniels; B Sibanda; Z Damse; V Scott; E von der Heyden; C Pfaff; A Reuter; J Furin
Journal:  Public Health Action       Date:  2022-06-21

4.  Risk factors for poor engagement in drug-resistant TB care in South Africa: a systematic review.

Authors:  K C McNabb; A Bergman; J E Farley
Journal:  Public Health Action       Date:  2021-09-21

5.  Acceptability, feasibility, and impact of a pilot tuberculosis literacy and treatment counselling intervention: a mixed methods study.

Authors:  Stephanie Law; Boitumelo Seepamore; Olivia Oxlade; Nondumiso Sikhakhane; Halima Dawood; Sheldon Chetty; Nesri Padayatchi; Dick Menzies; Amrita Daftary
Journal:  BMC Infect Dis       Date:  2021-05-18       Impact factor: 3.090

Review 6.  Defining high probability when making a diagnosis of asthma in primary care: mixed-methods consensus workshop.

Authors:  Luke Daines; Steff Lewis; Antonius Schneider; Aziz Sheikh; Hilary Pinnock
Journal:  BMJ Open       Date:  2020-04-20       Impact factor: 2.692

7.  Designing noninferiority tuberculosis treatment trials: Identifying practical advantages for drug regimens with acceptable effectiveness.

Authors:  Piero L Olliaro; Michel Vaillant
Journal:  PLoS Med       Date:  2019-07-12       Impact factor: 11.069

8.  What works best for ensuring treatment adherence. Lessons from a social support program for people treated for tuberculosis in Ukraine.

Authors:  Zulfiya Charyeva; Siân Curtis; Stephanie Mullen; Tatyana Senik; Olga Zaliznyak
Journal:  PLoS One       Date:  2019-08-26       Impact factor: 3.240

9.  Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis.

Authors:  Jonathon R Campbell; Dennis Falzon; Fuad Mirzayev; Ernesto Jaramillo; Giovanni Battista Migliori; Carole D Mitnick; Norbert Ndjeka; Dick Menzies
Journal:  Emerg Infect Dis       Date:  2020-03-17       Impact factor: 6.883

10.  Long-Term Mortality and Active Tuberculosis Disease Among Patients Who Were Lost to Follow-Up During Second-Line Tuberculosis Treatment in 2011-2014: Population-Based Study in the Country of Georgia.

Authors:  Giorgi Kuchukhidze; Davit Baliashvili; Natalia Adamashvili; Ana Kasradze; Russell R Kempker; Matthew J Magee
Journal:  Open Forum Infect Dis       Date:  2021-03-15       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.